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Summary
Objective: To examine the effect of topical administration of glyceryl trinitrate (GTN), an exogenous nitric oxide (NO) donor, on the structural
and biomechanical properties of uncalcified articular cartilage (UCC) in aged ewes.
Design: Twelve ewes were used for this study. Six of these were treated with 2% GTN ointment (0.7 mg/kg) twice per week (GTN), and the
remaining six were used as normal controls (NOC). After sacrifice at 26 weeks, dynamic biomechanical indentation testing and thickness
determination (by needle penetration) were performed on tibial plateau articular cartilage at 18 locations. Using histological sections
prepared from the lateral and medial femoral condyles (LFC, MFC) and tibial plateau (LTP, MTP), the thickness of UCC, cartilage
proteoglycan content (intensity of toluidine blue staining; LFC, MFC only), and collagen birefringence (LTP, MTP, LFC only) were quantified
by computer-assisted image analysis.
Results: Phase lag of tibial plateau cartilage was reduced in GTN sheep relative to NOC (mean of all testing locations 11.0±1.9° vs
12.1±2.3°; P0.0001). GTN treatment also globally reduced UCC thickness across the joint (ANOVA for all measured zones, P<0.0001).
UCC thinning was most pronounced in the MFC (P0.025) and LTP (P0.0002). Proteoglycan content was reduced in the MFC
(P0.019), while collagen birefringence was increased in superficial cartilage zones of the LTP.
Conclusions: NO donation via topical administration of GTN to normal ewes reduced the thickness and phase lag of femoro-tibial articular
cartilage, suggesting a disturbance in chondrocyte metabolism. Regional alterations of collagen organisation and proteoglycan content were
consistent with this interpretation.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Nitric oxide (NO) is a highly reactive free radical which is
emerging as an important mediator in many physiological
and pathophysiological processes. Evidence is accumulat-
ing that nitric oxide may play a role in the pathogenesis of
osteoarthritis (OA)1. Articular chondrocytes and synovio-
cytes, like many cell types, are capable of generating NO
via inducible nitric oxide synthase (iNOS), and in OA the
production of this enzyme is increased2,3. The conse-
quence of excess NO production in OA joints is contro-
versial, with experimental evidence of both deleterious and
chondroprotective roles1. NO is suspected to be a major
mediator of interleukin-1 (IL-1)-induced suppression of
proteoglycan (PG) synthesis, and has also been associ-
ated with matrix metalloprotease (MMP) synthesis and
chondrocyte apoptosis4,5. However, other investigators
have found evidence that NO can be protective under some
conditions6,7. Evidence from iNOS knockout studies8 and
experiments using iNOS inhibitors in animal models of
arthritis9–11 suggests that NO promotes the progression of
arthritic changes, but its exact role in autocrine regulation of
cartilage metabolism remains unclear.
Glyceryl trinitrate (GTN), or nitroglycerin, is a nitric oxide
donor used for many years as a vasodilator and for
symptomatic treatment of angina12. It has recently been
suggested that GTN may have clinical application in pre-
venting bone loss13,14. However, given evidence that ex-
cess NO may play a role as a mediator of the catabolism of
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joint tissues, the safety of NO-donor compounds may be
questioned. The aim of the present study was to examine
the effects of GTN, as a representative exogenous nitric
oxide donor, on the structural and biomechanical integrity
of normal articular cartilage in aged ewes.
Methods
ANIMALS
Twelve aged (7-year-old) Merino ewes were obtained
from a single source and selected for uniformity of size,
conformation, body condition, and absence of lameness.
All sheep were maintained on irrigated pasture for the
duration of the trial. Six of the sheep were used as normal
controls (NOC) and six were treated with 2% GTN ointment
[Nitro-Bid®, Hoescht, Australia] (GTN). GTN ointment was
applied twice weekly to the hairless region on the medial
aspect of the hindlimb (approximately 250 cm2), and
rubbed in well. The ointment was weighed to deliver a dose
of 0.7 mg GTN/kg body weight. This dosage regime was
selected to provide a weight-adjusted weekly dosage
(though at lower frequency) similar to that used in rat
studies by Wimalawansa et al.13,14, in which tissue-
modifying effects were demonstrated. All animal pro-
cedures were approved by the Murdoch University Animal
Ethics Committee.
Animal body weights were recorded at approximately
monthly intervals. The sheep were euthanised after 24–26
weeks of treatment, by intravenous injection of pentobarbi-
tone, using a blocking design such that equal numbers
of GTN-treated animals and controls were processed in
parallel at all times.
TISSUE PROCESSING
One leg (random left or right) was used for biomechani-
cal testing and tibial plateau histology, while the other was
used for assessment of gross pathology and femoral con-
dyle histology. The joint for biomechanical testing was
stored in ice for 24 h, before dissection and removal of the
entire proximal diaphyseal region of the tibia using a
bandsaw. Each sample was wrapped in gauze soaked
in phosphate-buffered saline (PBS) [Baxter Healthcare,
Australia], then stored frozen (−20°C) for less than 2 weeks
before biomechanical testing. Freeze–thaw of cartilage has
been shown to have no effect on its biomechanical proper-
ties15. The other joint was immediately dissected and
examined before formalin fixation of a femoral osteo-
chondral slab for histology. Joint surfaces were scored for
gross pathology (cartilage integrity, scores 0–4: 0=normal,
1=roughened, 2=fibrillated/fissured, 3=erosions <5 mm,
4=erosions >5 mm; osteophyte development, scores
0–3: 0=none, 1=mild, 2=moderate, 3=marked osteophyte
formation).
INDENTATION TESTING
The biomechanical properties of tibial articular cartilage
were assessed using a recently developed hand-held in-
dentation device16, as described previously17. Accuracy
and precision trials using this indenter on standard rubbers
and normal ovine tibial plateau have demonstrated excel-
lent correlations16. On the day of testing, the samples were
immersed in fresh PBS and equilibrated to 20°C for 45 min.
Using a grid projected onto the articular surface by a
modified slide projector, a 3×3 array was marked on the
cartilage surface of the lateral and medial tibial plateau with
Picro Sirius red stain (Fig. 1). At each of these locations
(n18), the indentation probe was pressed against the
surface with constant pressure whilst a flat cylindrical
non-porous indenter (0.7 mm diameter) applied a sinu-
soidal oscillation (20 Hz) to the cartilage surface. Dynamic
stiffness and phase lag () were continuously displayed on
a computer monitor. Depressing a digital foot switch in-
structed collection of data. The dynamic shear modulus,
G*, was calculated using the theory published by Hayes
et al.18. On completion of biomechanical testing, articular
cartilage thickness was determined at each location using a
published needle penetration method19.
HISTOLOGICAL METHODS
Histological sections were prepared from the medial and
lateral tibial plateau (MTP, LTP) and femoral condyles
(MFC, LFC). Slices (approximately 3 mm thick) were taken
from each region by bandsaw cuts in the medio-lateral
plane, perpendicular to the articular surface, by a single
operator using a standard protocol. Cuts were positioned in
the femoral condyles at the point of tibial contact in normal
stance, and in the tibial plateau at the level of the inter-
condylar eminences (Fig. 1). Toluidine blue- and Masson’s
trichrome-stained histological sections were prepared as
described previously20. Semi-quantitative histopathological
grading was performed according to a published modified
Mankin’s scoring system21. In each joint region, four zones
were scored: inner, middle, outer, and outer marginal
Fig. 1. Schematic representation of the sites of biomechanical
indentation testing (numbers 1–18) on the lateral (LO, lateral outer;
LM, lateral middle; LI, lateral inner) and medial (MI, medial inner;
MM, medial middle; MO, medial outer) regions of the tibial plateau.
Horizontal lines represent the level of prepared histological sec-
tions, and vertical lines represent the division of these sections into
outer, middle and inner cartilage zones.
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zones. Scoring was done by a single observer, according to
a six-point scale, and a mean aggregate score was deter-
mined as the average of these four zones.
Computer-assisted histomorphometric analysis was
completed as described previously20. Sections were
scanned directly using a slide scanner [Microtek Slidescan-
ner 35t plus; Model No. PTS-1950] and analysed using
image analysis software [ImagePro Plus v3.0.1; Media
Cybernetics, USA]. Uncalcified cartilage thickness (mm)
was determined from Masson’s trichrome-stained sections,
using a radial thickness algorithm within the software to
generate mean thickness measurements between lines
delimiting the cartilage surface and most advanced tide-
mark, after dividing the cartilage visually into thirds (such
that each arc segment comprised approximately one-third
of the total arc length) termed the outer, middle, and inner
zones. PG content was determined as the mean grey-scale
pixel intensity (white=0, black=255) of toluidine blue-
stained sections, in each of the above-mentioned zones of
the MFC and LFC only. Collagen birefringence was quan-
tified using a method similar to that of Arokoski et al.22, as
described elsewhere17. This technique uses the transmis-
sion of polarised light to assess both the amount and
structural regularity of matrix collagen present. Briefly,
digital images of Picro Sirius red-stained sections were
obtained under monochromatic polarised light (, 550 nm),
from which full-thickness birefringence profiles were plotted
using image analysis software. Birefringence profiles were
determined in above zones of the MTP and LTP, and in
full-thickness cartilage plugs obtained from the middle zone
of the LFC.
STATISTICAL ANALYSIS
All data presented express mean±standard deviation,
except for graphical figures which present mean±standard
error. Statistical comparisons were generated using
specialist software [Statview 5.0, SAS Institute Inc., USA],
using Student’s t-test to determine significant differences
between groups. When multiple zones or testing locations
were compared simultaneously to examine differences
across an entire region, zone (inner, middle, or outer) or
location was included as a second independent variable
using multiple analysis of variance (MANOVA) to analyse
variance across groups, and Fisher’s protected least sig-
nificant difference (Fisher’s PLSD) test to compare means
of the control and treated groups. Results of biomechanical
testing at individual locations are pooled for presentation
(but not analysis) to the equivalent outer (O), middle (M),
and inner (I) zones of the lateral (L) or medial (M) plateau
(n6 zones: MO, MM, MI; LO, LM, LI; Fig. 1). Birefringence
profiles were compared by Student’s t-test at each gradu-
ated level of normalised depth (0=cartilage surface,
100=calcified cartilage). A significance level of P0.05 was
used throughout.
Results
There was no significant difference in body weights
between groups throughout the duration of the trial. Gross
pathology was minimal and scores did not differ between
NOC and GTN animals. Soft fibrillated cartilage in the area
of the medial tibial plateau not protected by the meniscus
was a common finding in both groups.
Dynamic biomechanical testing (Fig. 2) revealed an
overall reduction in phase lag in tibial plateau cartilage of
GTN sheep relative to NOC (mean across all 18 testing
locations=11.0±1.9° vs 12.1±2.3°; P0.0001). Similarly,
tibial cartilage thickness as determined by needle penetra-
tion was reduced overall relative to NOC (mean across all
18 testing locations=0.93±0.47 vs 1.12±0.56 mm; P<
0.0001). Thinning of cartilage was most prominent in the
LTP. Dynamic stiffness was found to be significantly in-
creased overall in GTN sheep (mean across all 18 testing
locations=6.31±4.76 vs 5.59±5.06 N/mm; P0.009). How-
ever, when stiffness was corrected for cartilage thickness
Fig. 2. Dynamic shear modulus (G*), phase lag (), and cartilage
thickness (as determined by needle penetration) in the lateral (lo,
lateral outer; lm, lateral middle; li, lateral inner) and medial (mi,
medial inner; mm, medial middle; mo, medial outer) regions of the
tibial plateau of NOC (M) and GTN ( ) sheep. *Differs significantly
from NOC (P<0.05).
874 M. A. Cake et al.: Nitric oxide donor modifies ovine cartilage
as the dynamic shear modulus (G*) according to the theory
of Hayes et al.18, no overall difference was apparent,
though a significant increase was noted in the inner zone of
the LTP (P<0.0001) (Fig. 2).
Mean uncalcified cartilage (UCC) thickness measures
(Fig. 3) as determined by image analysis were comparable
to results using the needle probe. GTN-treated sheep had
lower mean UCC thickness in all regions, and this reduction
was statistically significant when comparing all 12
measured zones by ANOVA (P<0.0001). When analysed
by joint region, UCC thickness was significantly reduced in
the MFC (0.80±0.0.27 vs 0.93±0.32 mm; P0.024) and
LTP (0.76±0.36 vs 0.99±0.49 mm; P0.0002). Mean inten-
sity of toluidine blue staining, an index of cartilage PG
content, was significantly reduced in the MFC of GTN
animals (146.3±5.2 vs 152.4±6.4; P0.0194) (Fig. 4).
Collagen birefringence profiles revealed a distinct early
(superficial) peak in grey-scale intensity. Superficial zone
birefringence was significantly increased in GTN sheep in
the middle zone of the LTP, with similar changes in other
zones (Fig. 5). Superficial zone birefringence was also
significantly increased in full-thickness biopsy plugs ob-
tained from the middle zone of the LFC (data not shown).
Discussion
The results of this study reveal that topical application of
2% GTN to normal female sheep for 6 months caused
significant changes to the structural and biomechanical
properties of articular cartilage in some regions of the
femoro-tibial joint. Uncalcified cartilage of GTN-treated ani-
mals was observed to be thinner, by both direct (needle
penetration) and histomorphometric assessment, in most
regions tested. Biomechanical testing revealed an overall
reduction in cartilage phase lag across the tibial plateau,
and an increased shear modulus (G*) in the inner zone of
the LTP. A reduced affinity for toluidine blue stain (an index
of PG content) was found in MFC cartilage, while super-
ficial collagen birefringence was increased in the LFC and
middle zone of the LTP, with similar changes in some other
areas.
Values obtained for cartilage G* and phase lag were
comparable with those previously reported in other studies
assessing the shear properties of articular cartilage23–25.
Our own previous studies17 have indicated that lower
cartilage phase lag values reflect a change in viscoelastic
behaviour consistent with a more elastic solid, with de-
creased viscous dissipation of shear forces. It is known that
the relationship between the structural components of
cartilage and its phase properties is complex. Zhu et al.23
found a weak positive correlation between  and uronic
Fig. 3. Uncalcified cartilage thickness (mm±SE) in the inner, middle and outer zones of the lateral femoral condyle (LFC), medial femoral
condyle (MFC), lateral tibial plateau (LTP) and medial tibial plateau (MTP) of NOC (M) and GTN ( ) sheep. *Differs significantly from NOC
(P<0.05).
Fig. 4. Cartilage proteoglycan content (mean grey-scale pixel
intensity of toluidine blue-stained sections±SE) in the lateral fem-
oral condyle (LFC) and medial femoral condyle (MFC) of NOC (M)
and GTN ( ) sheep. *Differs significantly from NOC (P<0.05).
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acid content. However, more complex modelling recog-
nises the elastic mechanical responses of collagen, as well
as the importance of energy dissipation from PG–collagen
and PG–PG interactions25. Such interactions are influ-
enced by the abundance and molecular size of PGs, the
degree to which they form stable aggregates, and the
intactness of the collagen network which enmeshes
them25. Therefore, the reduction in phase lag in GTN-
treated animals may arise from a lower cartilage PG
content, some change in PG quality or aggregation state,
and/or an increase in collagen content or organisation.
Analysis of collagen birefringence suggests a regional
increase in collagen density and/or organisation in GTN-
treated animals, specifically localised to the superficial
layer of cartilage. The reduced toluidine blue staining
intensity observed in the MFC suggests that cartilage
PG content was also regionally reduced by GTN treatment.
These observations suggest a change in the structural
interrelationship of collagen and PG which is likely to
account for the generalised reduction in phase lag ob-
served in the tibial plateau cartilage of GTN-treated
sheep.
The increase in G* observed in the inner testing locations
of the LTP (Fig. 2) is significant, given that cartilage
resistance to shear is predominantly determined by its
collagen network23,26,27. In a similar ovine study, cartilage
G* was shown to be positively correlated to biochemically
determined collagen content17. The increase in G* ob-
served in the inner LTP in this study is therefore likely to be
the result of an increase in collagen content and/or organ-
isation, as mirrored by the increase in superficial collagen
birefringence in adjacent areas of the LTP. Le Roux et al.26
reported a similar relationship between shear modulus and
surface collagen birefringence in canine cartilage.
Several of the known actions of nitric oxide may explain
the effects observed. Firstly, NO has been shown to have
direct effects on chondrocyte metabolism, including sup-
pression of PG synthesis, increasing MMP synthesis, and
decreasing the level of (and response to) endogenous
growth factors4,28,29. The changes observed would be
consistent with prolonged suppression of chondrocyte PG
synthesis, and/or increased loss of PG due to elevated
MMP activity. Secondly, nitric oxide is known to influence
collagen synthesis in many cell types. In most connective
tissues, NO generally increases collagen synthesis30,31,
and may even promote collagen production during wound
healing32,33. However, NO has also been shown to de-
crease collagen production in some other tissues, including
mouse artery34 and rabbit cruciate ligament35. In the only
published study to examine the effect of NO on chondro-
cyte collagen synthesis36, it was observed that NO reduced
type II collagen production in lapine chondrocytes grown in
monolayer culture. This effect was attributed to the inhibi-
tion of the key enzyme prolyl-hydroxylase by NO. Changes
in collagen birefringence and G* observed in the present
study suggest that GTN in fact enhanced collagen organ-
isation in the superficial zone of articular cartilage in certain
regions, although the collagen type affected was not
identified here.
In conclusion, we present evidence that topical treatment
of ewes with GTN reduced the thickness and phase lag
of femoro-tibial articular cartilage, in association with a
regional alteration of collagen organisation and PG content
in these tissues. These findings are consistent with a
Fig. 5. Normalised collagen birefringence profile plots of inner, middle, and outer zones of the lateral (LTP) and medial (MTP) tibial plateau
of NOC ( ) and GTN ( ) sheep. *****Differs significantly from NOC at this depth (P<0.05).
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disturbance of chondrocyte metabolism, as might be pre-
dicted from the reported deleterious effects of nitric oxide
in cartilage4,5,28,29. If the present findings were applied
clinically, the safety of NO-donor compounds should be
questioned. Indeed, some epidemiological evidence of an
association between nitrate use and hip OA has been
presented37. However, this interpretation must be tem-
pered with several additional considerations. Firstly, it
should be noted that the cartilage changes observed in this
study after GTN treatment were not necessarily degener-
ative, since no evidence of gross or microscopic cartilage
pathology was observed. In experimental animal models,
OA is generally associated with reduced cartilage shear
modulus and increased phase lag, which is the opposite of
that observed here17,25,38. Instead, these changes suggest
more of an ‘atrophic’ effect, of which the long-term seque-
lae are unknown. Secondly, it should be noted that in this
study GTN treatment induced regional and not global
alteration of collagen organisation and PG content, with
most significant changes being limited to the LTP and MFC.
Thirdly, the inhibitory effects of nitric oxide in articular
cartilage are currently thought to be at least partly mediated
by generation of peroxynitrite, and are thus dependent on
the concurrent presence of superoxide radical39. The ef-
fects of GTN treatment may therefore be altered in patho-
logical circumstances such as OA. Nevertheless, the
current findings indicate the need for further epidemiologi-
cal investigation into the effects of GTN and other nitric
oxide donors on articular cartilage.
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